HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of α-secretase cleavage.

Abstract
Alpha-secretase-mediated cleavage of the amyloid precursor protein (APP) releases the neuroprotective APP fragment sαAPP and prevents amyloid β peptide (Aβ) generation. Moreover, α-secretase-like cleavage of the Aβ transporter 'receptor for advanced glycation end products' counteracts the import of blood Aβ into the brain. Assuming that Aβ is responsible for the development of Alzheimer's disease (AD), activation of α-secretase should be preventive. α-Secretase-mediated APP cleavage can be activated via several G protein-coupled receptors and receptor tyrosine kinases. Protein kinase C, mitogen-activated protein kinases, phosphatidylinositol 3-kinase, cAMP and calcium are activators of receptor-induced α-secretase cleavage. Selective targeting of receptor subtypes expressed in brain regions affected by AD appears reasonable. Therefore, the PACAP receptor PAC1 and possibly the serotonin 5-HT(6) receptor subtype are promising targets. Activation of APP α-secretase cleavage also occurs upon blockade of cholesterol synthesis by statins or zaragozic acid A. Under physiological statin concentrations, the brain cholesterol content is not influenced. Statins likely inhibit Aβ production in the blood by α-secretase activation which is possibly sufficient to inhibit AD development. A disintegrin and metalloproteinase 10 (ADAM10) acts as α-secretase on APP. By targeting the nuclear retinoic acid receptor β, the expression of ADAM10 and non-amyloidogenic APP processing can be enhanced. Excessive activation of ADAM10 should be avoided because ADAM10 and also ADAM17 are not APP-specific. Both ADAM proteins cleave various substrates, and therefore have been associated with tumorigenesis and tumor progression.
AuthorsRolf Postina
JournalJournal of neurochemistry (J Neurochem) Vol. 120 Suppl 1 Pg. 46-54 (Jan 2012) ISSN: 1471-4159 [Electronic] England
PMID21883223 (Publication Type: Journal Article, Review)
Copyright© 2011 The Author. Journal of Neurochemistry © 2011 International Society for Neurochemistry.
Chemical References
  • Amyloid beta-Protein Precursor
  • Amyloid Precursor Protein Secretases
Topics
  • Alzheimer Disease (enzymology, metabolism, pathology)
  • Amyloid Precursor Protein Secretases (antagonists & inhibitors, chemistry, metabolism)
  • Amyloid beta-Protein Precursor (chemistry, metabolism)
  • Animals
  • Enzyme Activation (physiology)
  • Humans
  • Protein Processing, Post-Translational (physiology)
  • Protein Transport (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: